Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transduction01:16

Transduction

62
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
62
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

64
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
64
Types of RNA01:23

Types of RNA

64.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.3K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

116
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
116

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Career Plateau Among Surgical Nurses: A Cross-Sectional Network Analysis.

Journal of nursing management·2026
Same author

Minimally invasive resection of solid intraventricular lesions via single burr-hole ventriculoscopy.

Frontiers in neurology·2026
Same author

ZEB1 drives terminal erythroid maturation by controlling the GATA2-KLF1 regulatory switch.

Nucleic acids research·2026
Same author

The effect of GLP-1 receptor agonists on osteoarthritis risk in individuals with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized controlled trials.

Acta diabetologica·2026
Same author

From Awareness to Participation: Diffusion of Innovation and Engagement of Older People in Barrier-Free Communities in Zhuhai, China.

Journal of aging & social policy·2026
Same author

Self-Supervised Continuous Colormap Recovery from a 2D Scalar Field Visualization without a Legend.

IEEE transactions on visualization and computer graphics·2025

Related Experiment Video

Updated: Aug 13, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K

Recent Advances on Small-Molecule Antagonists Targeting TLR7.

Haoyang Zheng1, Peiyang Wu2, Pierre-Antoine Bonnet3

  • 1Faculty of Pharmacy, Montpellier University, 34093 Montpellier, France.

Molecules (Basel, Switzerland)
|January 21, 2023
PubMed
Summary

Small molecule antagonists targeting Toll-like receptor 7 (TLR7) show therapeutic potential for immune-related diseases, cancer, and HIV. This review details structural features and activity of various heterocyclic compounds as TLR7 inhibitors.

Keywords:
TLR7antagonistsheterocycleinnate immunity

More Related Videos

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

11.7K
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

11.6K

Related Experiment Videos

Last Updated: Aug 13, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

12.5K
Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

11.7K
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

11.6K

Area of Science:

  • Immunology
  • Medicinal Chemistry

Background:

  • Toll-like receptor 7 (TLR7) is a key pattern recognition receptor in the innate immune system, crucial for immune regulation through cytokine and interferon release.
  • Abnormal TLR7 activation is linked to immune diseases, cancer, and HIV proliferation, highlighting the need for therapeutic interventions.

Purpose of the Study:

  • To provide an updated overview of small-molecule TLR7 antagonists.
  • To present the structural features, therapeutic potential, and structure-activity relationships (SAR) of these antagonists.

Main Methods:

  • Review of existing literature on small-molecule TLR7 antagonists.
  • Analysis of various heterocyclic scaffolds targeting TLR7 binding sites.
  • Examination of SAR studies, biological activities, and protein binding modes.

Main Results:

  • Identified diverse heterocyclic scaffolds including pyrazoloquinoxaline, quinazoline, purine, imidazopyridine, pyridone, benzanilide, pyrazolopyrimidine/pyridine, benzoxazole, indazole, indole, and quinoline as potential TLR7 antagonists.
  • Summarized SAR studies, biological activities, and binding modes for these compounds.

Conclusions:

  • Small-molecule TLR7 antagonists represent a promising therapeutic strategy for managing immune-related diseases, carcinogenesis, and HIV.
  • Further research into these compounds' structural features and SAR can lead to novel drug development.